Category: Pharmaceuticals

Fentanyl

What are the risks of touching fentanyl?

There is the widespread belief that simply touching fentanyl can be fatal. This assumption isn't supported by science or evidence.

/ July 21, 2022

Melatonin poisonings in children are increasing

Melatonin use is increasing, and accelerated during the pandemic. Overdoses are also increasing in children, and in rare cases are linked to serious harms.

/ July 7, 2022

Good faith doctoring or greedy drug dealing? SCOTUS hears opioid prescribing cases

Physicians running opioid "pill mills" were convicted of violating the Controlled Substances Act and given substantial prison sentences. The U.S. Supreme Court will soon decide whether they were entitled to a "good faith" defense at trial.

/ March 10, 2022

Two New Antivirals Targeting COVID-19

There are two new drugs on the horizon that actually work against COVID-19.

/ November 10, 2021
Ivermectin

Courts should not order hospitals and physicians to administer ivermectin against their will

Courts in several states have ordered hospitals to administer ivermectin to COVID patients against the medical judgment of treating physicians. Patients have no legal right to a particular treatment and health care providers should not be forced to administer this drug.

/ September 9, 2021

Genetic Testing for Selection of Psychotropic Medications

GeneSight is a blood test to determine which neuropsychiatric medications are indicated for an individual based on genetic analysis. The test is expensive and not likely to be helpful for most patients.

/ August 3, 2021

Near-fatal blood infection following naturopathic IV vitamin infusion

A patient nearly died from a blood infection after a compounded naturopathic vitamin infusion. IV vitamin infusions are a common naturopathic therapy used without adequate medical rationale and are not worth the risks.

/ July 29, 2021

FDA’s Decision to Approve Aduhelm (aducanumab) for Alzheimer’s

Criticism of the FDA's decision to approve aducanumab for Alzheimer's disease.

/ July 7, 2021
Alzheimer's Disease

No evidence, no problem: A closer look at the aducanumab approval

Why did the FDA approve aducanumab, a drug that hasn't been shown to work?

/ June 10, 2021